妊娠期疟疾间歇性预防治疗与胎盘疟疾对婴儿疟疾风险的影响
本研究基于马拉维一项比较IPTp-SP与IPTp-DP的随机临床试验,随访192名SP组和195名DP组婴儿至24月龄,评估IPTp方案及胎盘疟疾暴露对婴儿首次疟疾发作时间和恶丝虫感染发病率的影响。结果显示,IPTp方案或胎盘疟疾暴露均未显著影响婴儿期临床疟疾或感染发病率。
要点
- 婴儿性别、出生季节和母亲孕次未对结果产生混杂影响。
核心结论
- 本研究未发现IPTp方案或胎盘疟疾暴露影响该人群婴儿期疟疾风险的证据。
研究设计与样本
- 基于马拉维一项比较IPTp-SP与IPTp-DP的随机临床试验,随访婴儿从出生至24月龄。
- 共纳入192名母亲随机分配至IPTp-SP组的婴儿和195名分配至IPTp-DP组的婴儿。
主要发现
- 婴儿性别、出生季节和母亲孕次未对结果产生混杂影响。
临床怎么用
- 在该研究人群中,IPTp方案选择或胎盘疟疾暴露史不改变婴儿期疟疾风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intermittent preventive treatment of malaria during pregnancy (IPTp) with dihydroartemisinin-piperaquine (DP) provides greater protection from placental malaria than sulfadoxine-pyrimethamine (SP). Some studies suggest placental malaria alters risk of malaria infection in infants, but few have quantified the effect of IPTp on infant susceptibility to malaria. METHODS: Infants born to women enrolled in a randomized clinical trial comparing IPTp-SP and IPTp-DP in Malawi were followed from birth to 24 months to assess effect of IPTp and placental malaria on time to first malaria episode and Plasmodium falciparum incidence. RESULTS: In total, 192 infants born to mothers randomized to IPTp-SP and 195 randomized to IPTp-DP were enrolled. Infants in IPTp exposure groups did not differ significantly regarding incidence of clinical malaria (incidence rate ratio [IRR], 1.03; 95% confidence interval [CI], .58-1.86) or incidence of infection (IRR, 1.18; 95% CI, .92-1.55). Placental malaria exposure was not associated with incidence of clinical malaria (IRR, 1.03; 95% CI, .66-1.59) or infection (IRR, 1.15; 95% CI, .88-1.50). Infant sex, season of birth, and maternal gravidity did not confound results. CONCLUSIONS: We did not find evidence that IPTp regimen or placental malaria exposure influenced risk of malaria during infancy in this population. Clinical Trials Registration. NCT03009526.
引用
- Andronescu LR, Sharma A, Peterson I, et al. The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria. J Infect Dis. 2022. PMID: 34216212. doi:10.1093/infdis/jiab351
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。